
HHS Office of Inspector General finds continuing problems in federal provider-identification databases
Will inaccuracies in the National Plan and Provider Enumeration System (NPPES) create headaches for pharma?
On the verge of when the pharma industry needs to get serious about collecting and aggregating spending data on physicians,
In truth, the inaccuracies seldom included the National Provider Identifier (NPI), the key ID number for physicians and other providers, and the one that most pharma-industry databases are keyed to; more often, the inaccuracy involved address information. And these databases are more important to the Medicare payments that CMS makes, and for preventing fraud and abuse in that program, than for pharma’s agg-spend requirements. But the continuing difficulty highlights the complexity of keeping track, through regularly updated master-data lists, of the providers that the pharma industry interacts with.
Newsletter
Stay ahead in the life sciences industry with Pharmaceutical Commerce, the latest news, trends, and strategies in drug distribution, commercialization, and market access.